Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs NuuVim

Enhance MD
Graded #11

Higher grade

vs+16.599999999999994
NuuVim
Graded #153

Lower grade

The verdict

Enhance MD takes it — 84.8/100 to 68.2/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuuVim +6
82
88
Dose & formulationNuuVim +14
82
96
Clinical oversightEnhance MD +46
88
42
Labs & monitoringEnhance MD +40
90
50
FulfillmentEnhance MD +23
84
61
Contract termsEnhance MD +37
84
47
Enhance MD · left barNuuVim · right bar

The numbers

MetricEnhance MDNuuVim
WeighScore84.8/10068.2/100
GradeBC
Scorecard rank#11#153
Semaglutide$212/mo$79/mo (all doses, 3-mo plan, new patients only, compounded)
Tirzepatide$280/mo$133/mo (all doses, 3-mo plan, new patients only, compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Enhance MD

Graded #11 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs
NuuVim

Graded #153 · C

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where it loses points

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard